Nature Communications (Sep 2024)

Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma

  • Yang Liu,
  • Shuang-Yan Ye,
  • Shuai He,
  • Dong-Mei Chi,
  • Xiu-Zhi Wang,
  • Yue-Feng Wen,
  • Dong Ma,
  • Run-Cong Nie,
  • Pu Xiang,
  • You Zhou,
  • Zhao-Hui Ruan,
  • Rou-Jun Peng,
  • Chun-Ling Luo,
  • Pan-Pan Wei,
  • Guo-Wang Lin,
  • Jian Zheng,
  • Qian Cui,
  • Mu-Yan Cai,
  • Jing-Ping Yun,
  • Junchao Dong,
  • Hai-Qiang Mai,
  • Xiaojun Xia,
  • Jin-Xin Bei

DOI
https://doi.org/10.1038/s41467-024-52153-4
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 22

Abstract

Read online

Abstract Tertiary lymphoid structures are immune cell aggregates linked with cancer outcomes, but their interactions with tumour cell aggregates are unclear. Using nasopharyngeal carcinoma as a model, here we analyse single-cell transcriptomes of 343,829 cells from 77 biopsy and blood samples and spatially-resolved transcriptomes of 31,316 spots from 15 tumours to decipher their components and interactions with tumour cell aggregates. We identify essential cell populations in tertiary lymphoid structure, including CXCL13+ cancer-associated fibroblasts, stem-like CXCL13+CD8+ T cells, and B and T follicular helper cells. Our study shows that germinal centre reaction matures plasma cells. These plasma cells intersperse with tumour cell aggregates, promoting apoptosis of EBV-related malignant cells and enhancing immunotherapy response. CXCL13+ cancer-associated fibroblasts promote B cell adhesion and antibody production, activating CXCL13+CD8+ T cells that become exhausted in tumour cell aggregates. Tertiary lymphoid structure-related cell signatures correlate with prognosis and PD-1 blockade response, offering insights for therapeutic strategies in cancers.